Share on StockTwits

Cognex (NASDAQ:CGNX) Director Patrick Alias sold 7,500 shares of the company’s stock in a transaction that occurred on Monday, August 25th. The stock was sold at an average price of $43.20, for a total value of $324,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Separately, analysts at Zacks upgraded shares of Cognex from a “neutral” rating to an “outperform” rating in a research note on Tuesday, July 29th. They now have a $41.40 price target on the stock. One analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $50.28.

Shares of Cognex (NASDAQ:CGNX) traded down 3.08% during mid-day trading on Wednesday, hitting $41.87. 380,866 shares of the company’s stock traded hands. Cognex has a one year low of $27.07 and a one year high of $45.80. The stock’s 50-day moving average is $40.87 and its 200-day moving average is $37.31. The company has a market cap of $3.632 billion and a price-to-earnings ratio of 45.00.

Cognex (NASDAQ:CGNX) last released its earnings data on Monday, July 28th. The company reported $0.29 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.22 by $0.07. The company had revenue of $108.80 million for the quarter, compared to the consensus estimate of $103.30 million. During the same quarter last year, the company posted $0.38 earnings per share. Cognex’s revenue was up 25.8% compared to the same quarter last year. On average, analysts predict that Cognex will post $1.33 earnings per share for the current fiscal year.

Cognex Corporation (NASDAQ:CGNX) is a provider of machine vision products that capture and analyze visual information in order to automate tasks, primarily in manufacturing processes, where vision is required.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.